These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 2407013)

  • 21. [Drug-induced kidney damage].
    Schwarz A
    Z Arztl Fortbild (Jena); 1996 May; 90(3):205-12. PubMed ID: 8779233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug-induced nephropathy].
    Sakakima M; Hishida A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():94-8. PubMed ID: 18074522
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-induced renal toxicity: diagnosis and prevention.
    Farrugia E
    Hosp Med; 1998 Feb; 59(2):140-4. PubMed ID: 9797890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug-induced nephropathy].
    Shimizu H; Tanaka A; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():549-53. PubMed ID: 18074600
    [No Abstract]   [Full Text] [Related]  

  • 25. Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivatives.
    Lyubimova NV; Topchieva SV; Averinova SG; Kashkadaeva AV; Gorbunova VA; Shiryaev SV; Kushlinskii NE
    Bull Exp Biol Med; 2000 Sep; 130(9):886-91. PubMed ID: 11177273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of antibiotic-induced nephrotoxicity.
    Seale TW; Rennert OM
    Ann Clin Lab Sci; 1982; 12(1):1-10. PubMed ID: 6279013
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-associated renal dysfunction.
    Taber SS; Mueller BA
    Crit Care Clin; 2006 Apr; 22(2):357-74, viii. PubMed ID: 16678005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephrotoxin-induced tubulointerstitial nephropathies].
    Kliem V; Lonnemann G; Brunkhorst R
    Internist (Berl); 1996 Nov; 37(11):1116-28. PubMed ID: 9036107
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renal complications of anti-cancer chemotherapy].
    Fillastre JP; Moulin B; Godin M; Josse S
    Pathol Biol (Paris); 1986 Nov; 34(9):1013-28. PubMed ID: 3543812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.
    Yonezawa A; Inui K
    Biochem Pharmacol; 2011 Mar; 81(5):563-8. PubMed ID: 21144842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [About side effects of platinum drugs].
    Waszkiewicz K
    Postepy Hig Med Dosw; 2001; 55(3):387-406. PubMed ID: 11505639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoglycoside nephrotoxicity: keys to prevention.
    Levin ML
    J Crit Illn; 1994 Oct; 9(10):911-2, 915. PubMed ID: 10150695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and risk factors of colistin-induced nephrotoxicity.
    Kim J; Lee KH; Yoo S; Pai H
    Int J Antimicrob Agents; 2009 Nov; 34(5):434-8. PubMed ID: 19726164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug-induced nephropathy].
    Nakahama H; Tanabe K; Han S; Orita Y
    Nihon Rinsho; 1993 Jan; 51 Suppl():431-7. PubMed ID: 8459572
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute renal failure. 6. Renal failure caused by drugs or laboratory test procedures].
    Sakai O; OnoI
    Nihon Naika Gakkai Zasshi; 1993 Nov; 82(11):1807-11. PubMed ID: 8245608
    [No Abstract]   [Full Text] [Related]  

  • 37. [Research progress in mechanisms of drug-induced nephrotoxicity].
    Mao HX
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):330-4. PubMed ID: 24750824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renal insufficiency caused by medicines, diagnostic processes, toxins].
    Szegedi J
    Orv Hetil; 2007 Jan; 148(3):99-103. PubMed ID: 17289612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drugs an potential nephrotoxic substances].
    Sancewicz-Pach K; Ogarek I
    Przegl Lek; 2001; 58(4):185-90. PubMed ID: 11450332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
    Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.